Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis

被引:49
作者
Hofbauer, LC
Heufelder, AE
机构
[1] Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA
[2] Univ Munich, Klinikum Innenstadt, Med Klin, Div Endocrinol, D-8000 Munich, Germany
关键词
D O I
10.1530/eje.0.1390152
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:152 / 154
页数:3
相关论文
共 11 条
[1]  
ANDERSON MA, 1997, NATURE, V390, P175
[2]   Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation [J].
Lacey, DL ;
Timms, E ;
Tan, HL ;
Kelley, MJ ;
Dunstan, CR ;
Burgess, T ;
Elliott, R ;
Colombero, A ;
Elliott, G ;
Scully, S ;
Hsu, H ;
Sullivan, J ;
Hawkins, N ;
Davy, E ;
Capparelli, C ;
Eli, A ;
Qian, YX ;
Kaufman, S ;
Sarosi, I ;
Shalhoub, V ;
Senaldi, G ;
Guo, J ;
Delaney, J ;
Boyle, WJ .
CELL, 1998, 93 (02) :165-176
[3]   Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts [J].
Miyamoto, A ;
Kunisada, T ;
Hemmi, H ;
Yamane, T ;
Yasuda, H ;
Miyake, K ;
Yamazaki, H ;
Hayashi, SI .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 242 (03) :703-709
[4]   Bone and the hematopoietic and immune systems: A report of the proceedings of a scientific workshop [J].
Sharrock, WJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (04) :537-543
[5]   Osteoprotegerin: A novel secreted protein involved in the regulation of bone density [J].
Simonet, WS ;
Lacey, DL ;
Dunstan, CR ;
Kelley, M ;
Chang, MS ;
Luthy, R ;
Nguyen, HQ ;
Wooden, S ;
Bennett, L ;
Boone, T ;
Shimamoto, G ;
DeRose, M ;
Elliott, R ;
Colombero, A ;
Tan, HL ;
Trail, G ;
Sullivan, J ;
Davy, E ;
Bucay, N ;
RenshawGegg, L ;
Hughes, TM ;
Hill, D ;
Pattison, W ;
Campbell, P ;
Sander, S ;
Van, G ;
Tarpley, J ;
Derby, P ;
Lee, R ;
Boyle, WJ .
CELL, 1997, 89 (02) :309-319
[6]   Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells [J].
Tan, KB ;
Harrop, J ;
Reddy, M ;
Young, P ;
Terrett, J ;
Emery, J ;
Moore, G ;
Truneh, A .
GENE, 1997, 204 (1-2) :35-46
[7]   Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis [J].
Tsuda, E ;
Goto, M ;
Mochizuki, S ;
Yano, K ;
Kobayashi, F ;
Morinaga, T ;
Higashio, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 234 (01) :137-142
[8]   TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells [J].
Wong, BR ;
Rho, JR ;
Arron, J ;
Robinson, E ;
Orlinick, J ;
Chao, M ;
Kalachikov, S ;
Cayani, E ;
Bartlett, FS ;
Frankel, WN ;
Lee, SY ;
Choi, YW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) :25190-25194
[9]   Characterization of structural domains of human osteoclastogenesis inhibitory factor [J].
Yamaguchi, K ;
Kinosaki, M ;
Goto, M ;
Kobayashi, F ;
Tsuda, E ;
Morinaga, T ;
Higashio, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) :5117-5123
[10]   Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG):: A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro [J].
Yasuda, H ;
Shima, N ;
Nakagawa, N ;
Mochizuki, SI ;
Yano, K ;
Fujise, N ;
Sato, Y ;
Goto, M ;
Yamaguchi, K ;
Kuriyama, M ;
Kanno, T ;
Murakami, A ;
Tsuda, E ;
Morinaga, T ;
Higashio, K .
ENDOCRINOLOGY, 1998, 139 (03) :1329-1337